Amarin Corp Plc (AMRN)

[sts66]

Yes, they're worth less in a BO now because of the lost years of R-IT DTC ads and sales - but how do you figure the loss of $5B-$7B in sales would take double off the BO valuation (AMRN worth $7B-$10B less)? Those numbers are way too high in any case - AMRN may have only lost an extra $500M in sales due to this, and even that's questionable because FDA approval came so late last year V didn't get bumped up a tier on Medicare Part D 2020 plan formularies, and those sales won't show up until 2021.